Clinical Relapse Versus Treatment Failure: The Case for Surveillance for Re‐Appearance of Minimal Measurable Disease in Pediatric Patients with Higher Risk B‐ALL

Documenti analoghi

• Microphotopheresis for the Treatment of Graft‐Versus‐Host Disease in Pediatric Patients
  di: Irina Kumukova, et al.
  Pubblicazione: (2025)
• Bridging the Gap in Pediatric Relapsed Acute Lymphoblastic Leukemia Treatment: Insights and Outcomes From the ALL‐IC REL 2016 Guidelines
  di: Marko Kavcic, et al.
  Pubblicazione: (2025)
• Trametinib Monotherapy in the Treatment of Pediatric Refractory/Relapse Langerhans Cell Histiocytosis
  di: Wenqian Wang, et al.
  Pubblicazione: (2026)
• Transcriptomic Profiling of Relapsed Rhabdomyosarcoma: Pre‐ and Post‐Treatment Tissue Analysis Reveals Molecular Characteristics of Treatment Failure
  di: Andrew Muskara, et al.
  Pubblicazione: (2025)
• Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
  di: Andrew E. Place, et al.
  Pubblicazione: (2025)